Lhasa Xinbo

Lhasa Xinbo Biological Technology is a Chinese investment holding company primarily known as the controlling shareholder and strategic investment vehicle for Simcere Pharmaceutical Group. Based in Lhasa, Tibet, the company serves as a key entity for the management of interests in the life sciences sector, particularly those of the Ren family, founders of Simcere. Through its significant holdings in Simcere Pharmaceutical, Lhasa Xinbo is deeply integrated into the development, manufacturing, and commercialization of innovative therapies across oncology, neurology, and autoimmune diseases. The company also participates in venture investments and strategic partnerships within the broader healthcare and biotechnology ecosystem in China, supporting the growth of advanced therapeutic modalities and clinical-stage programs.